Creative Medical TechnologyCELZ
13F holders, Q2 2026 (June 30)13holders +2
4new positions
3sold out
$1.45avg. 13F price*
At the end of Q2 2026, 13 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, up 2 from Q1 2026. 4 opened new positions and 3 sold out. The largest holders were Hudson Bay Capital Management LP ($196K), Anson Funds Management LP ($153K) and Armistice Capital, LLC ($61K).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $410K |
| Exits | 3 | $32K |
All 13F filers, Q1 2026 → Q2 2026: 299,935 shares bought and 28,230 shares sold, net +271,705 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Hudson Bay Capital Management LP | 0.00% | New | 135,170 | $196K |
| Anson Funds Management LP | 0.01% | New | 105,549 | $153K |
| Armistice Capital, LLC | 0.00% | New | 42,000 | $61K |
| XTX Topco Ltd | 0.00% | Add +86.3% | 26,559 | $39K |
| Geode Capital Management, LLC | 0.00% | Reduce -32.6% | 25,799 | $37K |
| Vanguard Capital Management LLC | 0.00% | No change | 20,350 | $30K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 5,518 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +132.0% | 4,853 | $7K |
| Global Retirement Partners, LLC | 0.00% | — | 4,118 | $6K |
| UBS Group AG | 0.00% | Add +206000.0% | 2,061 | $3K |
| Morgan Stanley | 0.00% | Reduce -3.8% | 514 | $745 |
| Barclays PLC | 0.00% | New | 54 | $78 |
| SBI Securities Co., Ltd. | 0.00% | Add +4200.0% | 43 | $62 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.